Rocket Lab (RKLB) Stock Blasts Off: Japan Launch Deals and Analyst Upgrades Fuel 700% Rally
11 November 2025
3 mins read

Rocket Lab (RKLB) soars after Q3 beat: record $155M revenue, stronger margins and 2026 Neutron launch in sight — Nov. 11, 2025

Published: November 11, 2025

Rocket Lab shares are rallying into Tuesday after the space company posted record third‑quarter revenue, a sharp year‑over‑year margin jump, and fresh milestones on its next‑gen Neutron rocket. The stock rose more than 8% in after‑hours trading Monday and gained about 9% pre‑market Tuesday as investors digested the beat‑and‑raise update and a clearer 2026 path for Neutron. 1


What happened

Rocket Lab reported Q3 2025 revenue of $155.1 million, up 48% year over year, with a GAAP gross margin of 37% and a net loss of $0.03 per share—narrower than last year and ahead of Wall Street expectations. Management guided Q4 2025 revenue to $170–$180 million, targeting GAAP gross margin of 37%–39% and adjusted EBITDA loss of $23–$29 million. 2


By the numbers

  • Revenue: $155.1M in Q3 2025, +48% YoY. 2
  • Gross margin: 37% GAAP (record). 2
  • Earnings: Net loss $0.03 per share. 2
  • Q4 outlook: Revenue $170M–$180M; GAAP gross margin 37%–39%; adjusted EBITDA loss $23M–$29M. 2

LSEG/Reuters tallied the revenue beat vs. an analyst consensus near $151.8M and flagged the stock’s ~9% pre‑market pop to $56.70. 3


Operations snapshot: launches, defense work, and M&A

  • Launch cadence: Rocket Lab secured 17 Electron launch contracts in Q3 and remains on track for 20+ launches in 2025, setting up a new annual record. The company also completed two HASTE hypersonic test missions in the quarter. 2
  • National security build‑out: The quarter included the closing of the GEOST acquisition (up to $325M) to add EO/IR payload capabilities, plus progress tied to defense demand (e.g., SDA‑aligned programs). 2
  • Balance sheet: Rocket Lab ended the quarter with more than $1 billion in liquidity, aided by an at‑the‑market offering earlier this year. 2

Backlog and business mix

Management disclosed a ~$1.1 billion total backlog, split ~47% launch and ~53% space systems, indicating a balanced pipeline across rockets, spacecraft, and components. That mix matters for margins because space systems carry structurally higher gross profit than pure launch. 4


Neutron: 2026 is the new waypoint

Rocket Lab opened Launch Complex 3 (Wallops Island, VA) and updated the schedule for Neutron, its medium‑lift, partially reusable rocket. Neutron is now slated to arrive at LC‑3 in Q1 2026, with first launch thereafter pending qualification. In tandem, financial press coverage framed the next step as a “bigger launch planned for 2026,” which aligns with management’s “first launch thereafter” language. 2


Market reaction on Nov. 11, 2025

  • After‑hours (Nov. 10): RKLB jumped >8% following the earnings release. 1
  • Pre‑market (Nov. 11): Shares were up ~9.3% to $56.70, with Reuters citing the revenue beat, stronger near‑term guidance, and contract momentum. 3

Why it matters

Rocket Lab continues to evolve beyond “just launch.” The company’s space systems revenue base and defense‑oriented programs are expanding, while Electron maintains high cadence and HASTE opens a separate hypersonic‑testing revenue stream. With Neutron progressing toward the pad in 2026, Rocket Lab is positioning for larger‑payload missions—expanding its addressable market and potentially improving long‑term unit economics if reusability targets are met. 2


Key takeaways for investors and the industry

  • Execution + scale: Record quarterly revenue and margins alongside a rising launch cadence signal operational scale benefits, especially as higher‑margin space systems grow. 2
  • Backlog quality: A $1.1B backlog split across launch and space systems should support visibility into 2026 while smoothing quarter‑to‑quarter volatility typical of pure‑launch businesses. 4
  • Neutron milestone clarity: Arrival at LC‑3 in Q1 2026 with first launch thereafter gives the market a cleaner milestone map; WSJ coverage underscored the 2026 frame for the first Neutron mission. 2
  • Sentiment and price action: The revenue beat vs. LSEG consensus and the pre‑market jump show investors rewarding the mix of growth, margins, and pipeline updates. 3

What to watch next

  1. Q4 print vs. guidance: Can Rocket Lab land near the $170–$180M revenue range and sustain upper‑30s GAAP gross margin? 2
  2. Electron cadence: Contract conversion and launch execution as the company chases 20+ missions in 2025 and sets up 2026. 2
  3. Neutron readiness: Hardware qualification, engine/structures testing, and regulatory milestones toward the first flight after Q1 2026 arrival at LC‑3. 2
  4. Defense momentum: Integration of GEOST and follow‑on tasking in national‑security programs that value responsive launch and on‑orbit capabilities. 2

Sources (key Nov. 11, 2025 coverage and documents)

  • Company press release (Q3 2025 results, guidance, Neutron timing, M&A and liquidity). 2
  • WSJ live market coverage (after‑hours move; “bigger launch planned for 2026”). 1
  • Reuters/LSEG via TradingView (revenue vs. consensus; pre‑market price action). 3
  • Earnings‑call highlights (backlog level and mix). 4

This report is for informational purposes only and is not investment advice.

Stock Market Today

Anglo American share price slips after BofA downgrade as De Beers review looms

Anglo American share price slips after BofA downgrade as De Beers review looms

8 February 2026
London, Feb 8, 2026, 08:13 GMT — Market closed. Anglo American shares closed lower on Friday after BofA Global Research downgraded the miner to “neutral”, pointing to stretched valuation and a longer wait for catalysts tied to its overhaul. The stock ended at 3,435 pence, down 0.75%, with London markets shut on Sunday. 1 The timing matters. Anglo is trying to reshape itself around copper just as investors have paid up for the metal’s role in electrification, while legacy businesses like diamonds and coal still pull management time and capital. That leaves a narrow lane for the share price when
GSK stock price: EU nod for Nucala in COPD puts the focus on Monday trade

GSK stock price: EU nod for Nucala in COPD puts the focus on Monday trade

8 February 2026
GSK shares closed Friday up 0.8% at 2,198 pence after the EU approved expanded use of Nucala for adults with uncontrolled COPD. Chairman Jonathan Symonds bought 2,500 shares earlier in the week. The stock is up 17% over the past week and nearly 49% in 12 months. GSK trades ex-dividend on Feb. 19.
BAT stock ends week higher as buyback rolls on; investors eye Feb 12 results

BAT stock ends week higher as buyback rolls on; investors eye Feb 12 results

8 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence on Friday, outpacing the FTSE 100 ahead of its preliminary results due Feb. 12. The company bought back 121,668 shares this week for cancellation. CEO Tadeu Marroco received 364 shares under a bonus scheme. Investors are watching for updates on BAT’s nicotine alternatives and sector competition after Philip Morris International’s latest results.
SSE share price ends higher — what to watch before Monday’s London open

SSE share price ends higher — what to watch before Monday’s London open

8 February 2026
SSE shares closed up 1.21% at 2,510 pence in London on Friday, trading near a 52-week high. The company guided for 2025/26 adjusted earnings per share of 144–152 pence after reporting a 64% jump in regulated networks investment and a 7% rise in renewables output. Investors are watching Ofgem’s transmission price-control deadline and UK interest rate signals.
E. coli Alert: France Recalls Reblochon de Savoie AOP Sold at E.Leclerc, Grand Frais and Fresh — What to Check Now (November 10, 2025)
Previous Story

E. coli Alert: France Recalls Reblochon de Savoie AOP Sold at E.Leclerc, Grand Frais and Fresh — What to Check Now (November 10, 2025)

Schwab Orders Select Clients to Reset Logins, Joining Fidelity’s Credential‑Sharing Crackdown — Pontera Says Fidelity ‘Stands Alone’
Next Story

Schwab Orders Select Clients to Reset Logins, Joining Fidelity’s Credential‑Sharing Crackdown — Pontera Says Fidelity ‘Stands Alone’

Go toTop